Lineage Cell Therapeutics | 4:持股變動聲明-高管 Howe Jill Ann
Lineage Cell Therapeutics | 4:持股變動聲明-高管 Samuel George A. III
Lineage Cell Therapeutics | 4:持股變動聲明-高管 Culley Brian M
Lineage Cell Therapeutics | 4:持股變動聲明-高管 Samuel George A. III
Lineage Cell Therapeutics | 4:持股變動聲明-高管 Culley Brian M
Lineage Cell Therapeutics | 4:持股變動聲明-董事 BAILEY DON M
Lineage Cell Therapeutics | 4:持股變動聲明-董事 BROADWOOD PARTNERS, L.P.
Lineage Cell Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Neal C. Bradsher(22.2%),Broadwood Partners, L.P.(22.1%)等
Lineage Cell Therapeutics | 4:持股變動聲明-董事 Jayasuriya Anula
Lineage Cell Therapeutics | 4:持股變動聲明-董事 Mulroy Michael H.
Lineage Cell Therapeutics | 4:持股變動聲明-董事 BAILEY DON M
Lineage Cell Therapeutics | 4:持股變動聲明-董事 Amin Dipti
Lineage Cell Therapeutics | 4:持股變動聲明-董事 Russell Angus C.
Lineage Cell Therapeutics | 4:持股變動聲明-董事 ANDREWS DEBORAH J
Lineage Cell Therapeutics | 4:持股變動聲明-董事會主席 KINGSLEY ALFRED D
Lineage Cell Therapeutics | 4:持股變動聲明-董事 Jayasuriya Anula
Lineage Cell Therapeutics | 4:持股變動聲明-董事 BRADSHER NEAL C
Lineage Cell Therapeutics | 4:持股變動聲明-高管 Hogge Gary S.
Lineage Cell Therapeutics | 4:持股變動聲明-高管 Samuel George A. III
Lineage Cell Therapeutics | 4:持股變動聲明-高管 Culley Brian M
暫無數據